Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2007
03/29/2007US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
03/29/2007CA2623590A1 A preparation for treatment of non-infectious inflammatory intestinal diseases
03/29/2007CA2623304A1 Medicine, food and drink or feed containing sphingomyelin
03/29/2007CA2621811A1 Enhancer of cholinesterase activity
03/28/2007EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer
03/28/2007EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor
03/28/2007EP1767246A1 Composition for moistening oral cavity
03/28/2007EP1767201A1 Nutrient composition and composition for prevention/mitigation of digestive tract depression
03/28/2007EP1767200A1 Antiaging agent
03/28/2007EP1767198A1 Regulator of physiological function of ghrelin and use thereof
03/28/2007EP1765975A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
03/28/2007EP1765809A1 Xanthine derivatives useful as muscarinic receptor antagonists
03/28/2007EP1765807A1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
03/28/2007EP1765395A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease
03/28/2007EP1765345A2 A pharmaceutical composition having prokinetic effect and comprising o-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime
03/28/2007EP1765343A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
03/28/2007EP1765324A2 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids
03/28/2007EP1765320A2 Use of ppar agonists to treat ruminants
03/28/2007EP1545552B1 Combination therapy wherein a serotonin reuptake inhibitor is used
03/28/2007EP1500397B1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases
03/28/2007EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS
03/28/2007EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
03/28/2007EP1416958B1 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/28/2007EP1259239B1 USE OF 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLO[1,5-b]PYRIDAZINE FOR THE TREATMENT OF NON-ULCERATIVE DYSPEPSIA
03/28/2007EP1256581B1 Preventive or therapeutic agents for gastric or esophageal regurgitation
03/28/2007EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007EP0957806B1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h) LEVELS
03/28/2007EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine
03/28/2007EP0908182B2 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
03/28/2007CN1938311A Macrocyclic compounds as inhibitors of viral replication
03/28/2007CN1938226A Method for producing spherical activated carbon
03/28/2007CN1938037A Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease
03/28/2007CN1938026A Controlled-release pharmaceutical composition and method for producing the same
03/28/2007CN1936023A Diagnostic and monitoring methods for bone loss
03/28/2007CN1935847A Pearl oyster homogenous polysaccharide and its use for preparing liver health product and medicine
03/28/2007CN1935839A Analogues of glp-1
03/28/2007CN1935817A New acyclic nucleoside phosphate ester and its pharmaceutical use
03/28/2007CN1935802A Armiharisin succinic mono ester with cholagogic effect, and its salt and medicinal composition
03/28/2007CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/28/2007CN1935779A N-(N-benzoyl-phenylalanyl)-phenylalanine dipeptide derivative, and its preparing method and use
03/28/2007CN1935762A Pharmaceutical use of ent-eudesmane alcohol type sesquiterpene for inhibiting hepatitis virus
03/28/2007CN1935260A Human antibodies that bind human tnfalpha
03/28/2007CN1935250A Baoning pinellia tuber granules for relieving cough and sputum, and regulating stomach and stopping vomitting, and its production method
03/28/2007CN1935249A Drink for regulating liver and promoting urination
03/28/2007CN1935244A Health care tea for promoting digestion, invigorating spleen and promoting appetite
03/28/2007CN1935226A Health care medicinal liquor for longevity
03/28/2007CN1935213A Use of total saponinof sapindusmukeossi for preparing clinical medicine
03/28/2007CN1935212A Chinese medicine preparation for treating gastrosia
03/28/2007CN1935204A Health care medicinal liquor for nourishing kidney and strengthening yang
03/28/2007CN1935199A Quality control method for Chinese medicine compound preparation
03/28/2007CN1935196A Health care medicinal liquor for longevity
03/28/2007CN1935181A Animal medicament with tonifying qi and strengthening exterior, pusdraining and toxin-expelling, and its preparing method
03/28/2007CN1935173A Animal medicament with expelling toxin bycooling, purging liver to brighten vision and its preparing method
03/28/2007CN1935170A Animal medicament with nourishing qi to invigorate spleen, tonifying kidney to relieve mental strain and its preparing method
03/28/2007CN1935166A Health-care medicinal liquor for nourishing kidney and strengthening yang
03/28/2007CN1935164A Use of scaphium scaphigerum for preparing medicine for volumetrically treating astriction
03/28/2007CN1935163A Animal medicament with expelling toxin by cooling and cooling blood to stop diarrhea and its preparing method
03/28/2007CN1935156A Remedy
03/28/2007CN1935155A Remedy
03/28/2007CN1935140A Compound diphenidol hydrochloride dispersible tablet, and its preparing method
03/28/2007CN1935139A Substituted benzimidazole proton pump inhibitor composition, and its preparing method
03/28/2007CN1935138A Matrix for sustained, invariant and independant release of active compounds
03/28/2007CN1935133A Human leucocyte antigen DR4 subtype protein agonist
03/28/2007CN1935131A Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus
03/28/2007CN1935116A Composition for oral cavity and selection method for product of oral cavity
03/28/2007CN1934943A Use of steroid sapogenin compound as bacteriocide
03/28/2007CN1307196C Modified CpG oligodeoxynucleotide with improved immunoregulatory function
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307176C Novel alkoxypyridine-derivatives
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1307157C Novel compounds
03/28/2007CN1307156C Polyarylcarboxamides useful as lipid lowering agents
03/28/2007CN1307147C 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
03/28/2007CN1306964C Decoy composition for treating and preventing inflammatory disease
03/28/2007CN1306957C Anti infantile diarrhoed pathogenic bacteria immune milk product and its production method
03/28/2007CN1306955C Sodium ferulic acid albumin nano granular preparation and its preparing method
03/28/2007CN1306950C Kidney-invigorating and Yang-strengthening medicine and method for preparing same
03/28/2007CN1306945C Chinese Medicinal prescription for treating oral ulcer
03/28/2007CN1306942C Chinese medicine composition for treating recurrent ulcer of mouth
03/28/2007CN1306932C Medication for lowering level of endotoxin in human blood
03/27/2007USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations
03/27/2007US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/27/2007US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007US7196199 Phenoxypropylamine compounds
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196111 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196099 Compounds and compositions as cathepsin inhibitors
03/27/2007US7196098 Quinuclidine derivatives and medicinal compositions containing the same
03/27/2007US7196096 Substituted amines of spirofuropyridines useful in therapy
03/27/2007US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents
03/27/2007US7196080 Respiratory system disordeers; chronic obstructive pulminary disease
03/27/2007US7196077 Tachykinin antagonists
03/27/2007US7196076 Androgen receptor modulators and methods of use thereof
03/27/2007US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome
03/27/2007US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders
03/27/2007US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
03/27/2007US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
03/27/2007US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 1258